Docket #: S05-206
Fluorescent Cell Barcoding (FCB) in Flow Cytometry to Enable High-Throughput Drug Screening and Large-Scale Signaling Profiling
Applications
- High-throughput screening in drug development
- Large-scale signaling profiling
Advantages
- Increased throughput, compared to current methods in flow cytometry, with an acquisition time of 5-15 minutes per 96-well plate
- Decreased cost in sample labeling with 100-fold reduced antibody consumption
Publications
- Krutzik PO and Nolan GP, "Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling." Nature Methods 3, 361 - 368 (2006)
Patents
- Published Application: 20080241820
- Published Application: 20110263457
- Issued: 8,003,312 (USA)
Similar Technologies
-
CytoTrace2: Methods and Systems for Determining Phenotypic States from Genomic Data with Interpretable AI S24-057CytoTrace2: Methods and Systems for Determining Phenotypic States from Genomic Data with Interpretable AI
-
Methods enabling infection and differentiation of human distal lung organoids by SARS-CoV-2 and other pathogens S20-312Methods enabling infection and differentiation of human distal lung organoids by SARS-CoV-2 and other pathogens
-
Non-invasive Blood Test for Diagnosing Crohn's Disease and Ulcerative Colitis S18-217Non-invasive Blood Test for Diagnosing Crohn's Disease and Ulcerative Colitis